An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE
Clinical trial NCT01106482 · COMPLETED
Trial details
- NCT number
- NCT01106482
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2011-05-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.